Metabolon key facts
as of Oct 2026- Developer of metabolomic profiling technologies designed for biochemical data interpretation and to transform complex biological data discoveries.
- Metabolon is valued at approximately $187.3M as of Oct 2026 (last reported valuation).
- It has raised $345.9M across 8 recorded rounds; the latest was Early Stage VC ($7.5M) in Dec 2024.
- Notable investors include Perceptive Advisors, Revelation Partners, Syngenta Group Ventures, Camden Partners, Fulcrum Financial Partners — 10 tracked in total.
- Metabolon has filed 14 Form Ds with the SEC since 2009, most recently Jan 2025 ($7.5M sold to 11 investors).
- Status: Privately Held (backing).
Metabolon's last reported valuation, Aug 2018. Nothing priced has surfaced since.
- ·Watch Metabolon: the Monday email on marks, rounds and moves
Metabolon funding rounds
8 roundsMetabolon valuation
Metabolon's last reported valuation was $187 million in Aug 2018. No priced round, secondary trade or fund mark has surfaced since.
How much has Metabolon raised?
Metabolon has raised $346 million in total; 8 of its rounds are on record, from 2013 on. The largest on record was a $7.8 million early-stage round in Aug 2019; the most recent was a $7.5 million early-stage round in Dec 2024.
Metabolon has filed 14 Form Ds with the SEC since 2009, most recently in Jan 2025 ($7.5 million sold to 11 investors).
Metabolon investors
10 investors are on record for Metabolon, including Perceptive Advisors, Revelation Partners, Syngenta Group Ventures and Camden Partners. The early-stage round in Dec 2024 drew 11 investors.
About Metabolon
Developer of metabolomic profiling technologies designed for biochemical data interpretation and to transform complex biological data discoveries. The company's technologies integrate proprietary reference libraries, high-throughput analytical techniques, and bioinformatics tools to deliver annotated metabolite data, pathway mapping, and translational insights, enabling life sciences researchers and pharmaceutical developers to uncover biological mechanisms, accelerate discovery, enhance clinical development, and complement other omics approaches with precise molecular context and scalable data outputs.
- Sector
- Healthcare
- HQ
- Morrisville, NC, United States
- Founded
- 2000
- Employees
- 278
- Website
- metabolon.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.